Wall Street Analyst Warns of 20% Downside for Arm Stock

Friday, 17 May 2024, 14:25

Investors who bid up Arm stock after earnings may have made a mistake. Despite a recent surge, investment bank Bernstein suggests that Arm's stock is overpriced and should be sold, not bought. With a high valuation and moderate growth expectations, Bernstein's sell recommendation raises concerns about Arm's future performance and stock price. Are investors underestimating the risks associated with Arm Holdings?
https://store.livarava.com/19a30143-145a-11ef-a6c2-63e1980711b2.jpg
Wall Street Analyst Warns of 20% Downside for Arm Stock

Insights on Arm Stock Downside

Investors bid up Arm after earnings, but that was exactly the wrong decision. In the week since Arm Holdings (NASDAQ: ARM) released fiscal year 2024 results, shares of the UK-based semiconductor chip designer have gained 8%, surging past $114 a share.

The bad news is that, according to investment bank Bernstein, buying Arm's stock after earnings was exactly the wrong thing to do. In a report released Thursday, Bernstein argued that Arm's stock remains overpriced, and should actually be sold, not bought.

Key Points:

  • Arm's sales grew only 21% in fiscal 2024, with declining net income.
  • Fourth-quarter results showed significant momentum, but full-year performance could be different.
  • Bernstein raised concerns about Arm's high valuation and moderate growth outlook, recommending to sell.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe